Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C10F18
CAS Number:
Molecular Weight:
462.08
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
206-192-4
Beilstein/REAXYS Number:
2067113
MDL number:
Assay:
≥94% (GC)
Form:
liquid
InChI
1S/C10F18/c11-1-2(12,5(17,18)9(25,26)7(21,22)3(1,13)14)6(19,20)10(27,28)8(23,24)4(1,15)16
InChI key
UWEYRJFJVCLAGH-UHFFFAOYSA-N
SMILES string
FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F
assay
≥94% (GC)
form
liquid
refractive index
n20/D 1.314 (lit.)
bp
141-143 °C (lit.)
Quality Level
functional group
fluoro
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Thore Henrichsen et al.
Pediatric pulmonology, 47(4), 415-419 (2011-10-19)
Persistent lung atelectasis is difficult to treat and perfluorochemical (PFC) liquid may be an option for bronchioalveolar lavage (BAL). A 4-year-old girl with spinal muscle atrophy was admitted in respiratory failure. On admission, the X-ray confirmed the persistence of total
Qiang Li et al.
Analytical chemistry, 82(12), 5260-5267 (2010-05-25)
Off-line analysis and characterization of samples separated by capillary liquid chromatography (LC) has been problematic using conventional approaches to fraction collection. We demonstrate collection of nanoliter fractions by forming plugs of effluent from a 75 mum inner diameter LC column
Pieter Hindryckx et al.
Laboratory investigation; a journal of technical methods and pathology, 91(9), 1266-1276 (2011-06-29)
Intestinal inflammation is associated with enhanced mucosal hypoxia, which contributes to the ongoing inflammatory process and hampers appropriate mucosal healing. We questioned whether local treatment with an oxygen (O(2))-carrying and -releasing molecule (oxygenated perfluorodecalin, O(2)-PFD) could positively influence the course
Yong Taik Lim et al.
Biomaterials, 31(18), 4964-4971 (2010-03-30)
Multimodal imaging contrast agents with unique magnetic resonance (MR) and optical imaging capabilities have great potentials in the diagnosis and therapy of disease. Using a rational materials design approach, the bimodal imaging contrast agent, perfluorodecalin (PFD)/[InGaP/ZnS quantum dots (QDs)] composite
F Tamimi et al.
European cells & materials, 25, 22-36 (2013-01-04)
Perfluorodecalin (PFD) is a chemically and biologically inert biomaterial and, as many perfluorocarbons, is also hydrophobic, radiopaque and has a high solute capacity for gases such as oxygen. In this article we have demonstrated, both in vitro and in vivo
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service